If approved, levacetylleucine could become the first therapy on the market for ataxia-telangiectasia.

Your doctor may give you a prescription, but it comes with a warning ...

CARVYKTI ® is the first and only BCMA-targeted CAR-T cell therapy approved for the treatment of patients with multiple myeloma who have had at least one prior line of therapy. Globally, CARVYKTI ® is ...

Phase 3 trial results show levacetylleucine improves SARA scores in patients with the rare disorder ataxia-telangiectasia.

For decades, the fitness industry has been running the same tired script on repeat. Move your body to shrink it. Sweat to earn food. Exercise until your jeans fit differently. And honestly? We are ...

A brain cap and smart algorithms may one day help paralyzed patients turn thought into movement—no surgery required.

A breakthrough method from the 1990s is now being transformed into an AI-powered tool to help doctors diagnose cerebral palsy ...

Ataxia is a condition caused by damage in cerebellum, a part of the brain, that leads to poor muscle control affecting movement. In an interview with HT Lifestyle, Dr Aniruddha More, consultant ...

Flexibility test at 60, guided by a certified trainer, using 3 seated movements to assess hips, spine, and hamstrings.

After a month of holiday celebrations, travel, and indulgence, many people begin the new year feeling heavier or low on energy—and unsure where to restart. As you reset your goals and reconnect with ...

The California Institute for Regenerative Medicine (CIRM) has awarded $7.4 million to support a University of California San Diego team developing a first-of-its-kind stem cell-based gene therapy for ...

The DWP has issued a full list of 533 conditions which could qualify you for a £187 a week payment. Personal Independence ...